Nexus Pharmaceuticals Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Chicago, IL USA
Total Funding:N/A
Industry:Pharma
Founded:2003
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Nexus Pharmaceuticals's estimated annual revenue is currently $14.1M per year.
  • Nexus Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Nexus Pharmaceuticals has 70 Employees.
  • Nexus Pharmaceuticals grew their employee count by 43% last year.
  • Nexus Pharmaceuticals currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$35.4M176N/AN/A-N/A
#2
$12.3M6124%N/A-N/A
#3
$89.6M44619%N/A-N/A
#4
$4M20N/AN/A-N/A
#5
$23.5M117-13%N/A-N/A
#6
$11.1M552%N/A-N/A
#7
$14.1M7043%N/A-N/A
#8
$31.8M158N/AN/A-N/A
#9
$21.3M106N/AN/A-N/A
#10
$22.5M112N/AN/A-N/A
Missing a competitor? Contribute!?
Submit

Nexus Pharmaceuticals, Inc. is a niche Generic pharmaceutical company located in 175 E Hawthorn Pkwy, Vernon Hills, Illinois, United States.

keywords:N/A

70

Number of Employees

$14.1M

Revenue (est)

1

Current Jobs

43%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Nexus Pharmaceuticals News

09/03/2019 - Nexus Pharmaceuticals acquires land from Pleasant Prairie for new facility

An affiliate of Lincolnshire, Illinois-based Nexus Pharmaceuticals Inc. has purchased 16 acres of land from the village of Pleasant Prairie where ...

09/08/2019 - Wetlands rezoned to make way for pharmaceutical facility

During a special meeting, the board voted 5-0 to rezone two wetland areas to the west and south of the property for the Nexus Pharmaceuticals ...

09/03/2019 - United Conveyor to create 50 jobs in Pleasant Prairie

Also up for review is the first phase of a new drug manufacturing facility for Nexus Pharmaceuticals Inc. Nexus of Lincolnshire, Illinois, selected ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
N/A7216%N/A-N/A
#2
$14.9M74-6%N/A-N/A
#3
$31.1M8813%N/A-N/A
#4
$22.3M916%N/A-N/A
#5
$21.7M950%N/A-N/A